PRAXIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Praxis Precision Medicines, Inc. on Behalf of Praxis Stockholders and Encourages Investors to Contact the Firm

Benzinga
2025.08.23 14:33

Bragar Eagel & Squire, P.C. 正在代表可能遭受損失的股東調查 Praxis Precision Medicines, Inc.。該調查重點關注在 Praxis 發佈 2025 年第二季度財務結果後，可能違反聯邦證券法的情況。財務結果顯示其抗癲癇藥物研究中出現不良事件，導致股價下跌 5.55%。鼓勵投資者聯繫該公司以瞭解法律選擇

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.